Trinity Biotech Plc - ADR
TRIB
Get informed when a big investor buys or sells
+ FollowMarket Cap$251.72M
Close$
$-0.55
104.6% downside
Current Fair Value
104.6% downsideOvervalued by 104.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $251.72 Million |
|---|---|
| Enterprise Value | $384.56 Million |
| Dividend Yield | $33.00 (-) |
| Earnings per Share | $-60 |
| Beta | 1 |
| Outstanding Shares | 620,920 |
Return
| Return on Equity | 51.99% |
|---|---|
| Return on Assets | -35.58% |
| Return on Invested Capital | 38.28% |
Valuation & Multiples
| P/E Ratio | -0.21 |
|---|---|
| PEG | -6.86 |
| Price to Sales | 0.17 |
| Price to Book Ratio | -0.1 |
| Enterprise Value to Revenue | 8.77 |
| Enterprise Value to EBIT | -27.87 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | -1.92 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 16, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
$10.68 M
Average shareholder expectationNext Earnings Call
Expected Date
September 3, 2026
EPS Estimate
$-7.80
Average shareholder expectationRevenue Estimate
$10.31 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.90%▼ 0.86% |
|---|---|
| Total Invested | $348,199▼ 40.87% |
| Investors Holding | 9▼ 16.00% |
ESG Score
No data